FDA approves Artoss’ NanoBone SBX Putty

Foley, Minn.-based biotech Artoss recently earned market clearance from the Food and Drug Administration for NanoBone SBX Putty.

Advertisement

NanoBone SBX Putty is a synthetic bone replacement material intended to stimulate quicker bone formation, according to the NanoBone’s website.

Artoss plans to introduce the product to the U.S. market in the next few weeks.

More articles on supply chain:

5 trends on the growing role of digitization in supply chain
FDA approves expanded use of Janssen’s Darzalex for multiple myeloma patients
Texas Blood Center in desperate need of O-negative blood

 

 

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.